Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer ; volume:17 ; number:1 ; day:7 ; month:11 ; year:2017 ; pages:1-16 ; date:12.2017
BMC cancer ; 17, Heft 1 (7.11.2017), 1-16, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Quintero, Melissa
- Contributor
-
Adamoski, Douglas
Reis, Larissa Menezes dos
Ascenção, Carolline Fernanda Rodrigues
Oliveira, Krishina Ratna Sousa de
Gonçalves, Kaliandra de Almeida
Dias, Marília Meira
Carazzolle, Marcelo Falsarella
Dias, Sandra Martha Gomes
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3726-2
- URN
-
urn:nbn:de:1111-20180106673
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Quintero, Melissa
- Adamoski, Douglas
- Reis, Larissa Menezes dos
- Ascenção, Carolline Fernanda Rodrigues
- Oliveira, Krishina Ratna Sousa de
- Gonçalves, Kaliandra de Almeida
- Dias, Marília Meira
- Carazzolle, Marcelo Falsarella
- Dias, Sandra Martha Gomes
- SpringerLink (Online service)
Other Objects (12)
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes
Structural requirements for membrane binding of human guanylate-binding protein 1
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes
Structural requirements for membrane binding of human guanylate-binding protein 1
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes